Results 171 to 180 of about 59,669 (311)

Plasma cell‐directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In severe forms of monoclonal gammapathy associated with scleromyxoedema with dermatoneuro syndrome and/or cardiac involvement, deep and durable responses allowing IVIG withdrawal could be achieved using anti‐plasma cell therapy, including Imids, anti‐CD38 or proteasome inhibitors. Abstract Background Scleromyxedema (SM) is a rare skin disorder related
F. Theves   +12 more
wiley   +1 more source

Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients

open access: yes
Australasian Journal of Dermatology, EarlyView.
Vera Y. Miao   +3 more
wiley   +1 more source

Synthesis and <i>in vitro</i> antiprotozoal evaluation of novel Knoevenagel hydroxychloroquine derivatives. [PDF]

open access: yesRSC Med Chem
Dario PP   +9 more
europepmc   +1 more source

Impact of A Multidisciplinary Team Discussion for Genetic Lung Fibrosis

open access: yesRespirology, EarlyView.
ABSTRACT Background and Objective Approximately 30% of individuals diagnosed with familial pulmonary fibrosis (FPF) exhibit a pathogenic variant upon genetic analysis. We established a genetic Multidisciplinary Discussion (geneMDD) aimed to enhance expertise in diagnosing and managing FPF.
Giovanni Franco   +30 more
wiley   +1 more source

Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes

open access: green, 2006
Wan‐Uk Kim   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy